Feeds: 
Follow Us:
Researchers at UCLA’s Jonsson Comprehensive Cancer Center found that the quality of life (QOL) in younger breast cancer patients is seriously compromised and these women often suffer from severe psychological distress, infertility, premature menopause, a decrease in physical activity and weight gain. The study found that the mental issues faced by younger breast cancer [...]
Why do so many postmenopausal women who are treated for estrogen-sensitive breast cancer quit using drugs that help prevent the disease from recurring? The first study to actually ask the women themselves — as well as the largest, most scientifically rigorous study to examine the question — reports 36 percent of women quit early because [...]
While mammograms certainly play an important role in the early detection of breast cancer (and women have responded to this selling point), when weighed against other issues related to quality of life, this benefit becomes the question of debate among the scientific community. While researchers have ways to measure quality of life via quality-adjusted life [...]
High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence. They are [...]
A clinical trial to see if a gel containing an active form of tamoxifen, an anti-estrogen therapy, can provide the drug’s benefits with decreased risk of adverse health effects compared to those who take the oral tamoxifen is being conducted at Northwestern Medicine. The new study drug is being tested on participants recently diagnosed with [...]
The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The test, called Inform Dual ISH, allows for measurement of the number of copies of the HER2 [...]
Today, June 2, 2011, the U.S. Food and Drug Administration (FDA) warned women not to substitute breast thermography for mammography to screen for breast cancer. Some health care providers are promoting breast thermography on their websites and claiming that thermography is superior to mammography as a screening method for breast cancer, because it does not [...]
Choosing a treatment option for breast cancer can be almost as confusing and frightening as the diagnosis itself. But it doesn’t have to be. A new study from the University of Michigan has found that women make smarter choices about treatments when they receive information and make decisions in small doses rather than all at [...]
Women who have experienced hot flashes and other symptoms of menopause may have a 50 percent lower risk of developing the most common forms of breast cancer than postmenopausal women who have never had such symptoms, according to a recent study by researchers at Fred Hutchinson Cancer Research Center. The results of the first study [...]
Painful Hip Fractures Strike Breast Cancer Survivors A hip fracture is not common in a 54-year-old woman, unless she is a 54-year-old breast cancer survivor, according to a new Northwestern Medicine study. Researchers found that a combination of early menopause due to breast cancer treatment and common drugs used to treat breast cancer, could be [...]
Northwestern University | Northwestern Calendar: Plan-It Purple | Northwestern Search
Woodruff Lab | 303 E Superior Street, Suite 10-121, Chicago Illinois 60611 | Phone: 312-503-2504
World Wide Web Disclaimer | University Policy Statements | © 2010 Northwestern University
English